Topiramate Cost: What You'll Actually Pay in 2026 (With and Without Insurance)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Generic topiramate costs $4 to $80 per month with insurance depending on your formulary tier, typically landing on Tier 1 (lowest copay) across most commercial and government plans
• Cash prices for generic topiramate range from $15 to $150 per month at major pharmacies, with significant variation by dose and tablet count
• Brand-name Topamax costs $300 to $600 per month with insurance and $900 to $1,400 without, making generic the economically rational choice for 98% of patients
• The most common pricing mistake is filling a 30-day supply when your plan covers 90-day fills at lower per-pill cost, leaving $60 to $120 in annual savings on the table

Direct answer (40-60 words)

Generic topiramate costs $4 to $80 per month with insurance in 2026, depending on your plan's formulary tier and whether you've met your deductible. Without insurance, expect $15 to $150 per month at major retail pharmacies. Brand-name Topamax runs $300 to $600 with insurance, $900 to $1,400 cash, making it rarely cost-justified.

Table of contents

1. How topiramate pricing actually works (generic vs brand)
2. Real insurance copay scenarios across 6 plan types
3. Cash prices by dose at major pharmacy chains
4. The four variables that determine your specific cost
5. Walmart $4 generic program: does topiramate qualify?
6. Manufacturer assistance programs and discount cards
7. What most articles get wrong about topiramate cost
8. The 90-day supply calculation most patients miss
9. When brand-name Topamax costs less than generic (rare scenarios)
10. How to verify your exact cost in under 10 minutes
11. The compounded topiramate question
12. FAQ

How topiramate pricing actually works (generic vs brand)

Topiramate went generic in 2009 when Janssen Pharmaceuticals' patent on Topamax expired. Since then, more than 15 manufacturers produce FDA-approved generic versions, creating strong price competition.

The pricing split is dramatic:

Generic topiramate (made by Teva, Mylan, Aurobindo, Zydus, and others): $15 to $150 per month cash, $4 to $80 with insurance.

Brand-name Topamax (Janssen): $900 to $1,400 per month cash, $300 to $600 with insurance.

The medications are bioequivalent. The FDA requires generic topiramate to deliver the same active ingredient concentration, absorption rate, and clinical effect as Topamax. The difference is the manufacturer's name on the label and the price tag.

Most insurance plans automatically substitute generic topiramate unless your provider writes "dispense as written" (DAW) on the prescription, which forces the pharmacy to fill brand-name Topamax. When DAW is written, your insurance may refuse to cover the brand or may move it to a high specialty tier with 30-40% coinsurance.

Three things determine whether you pay $4 or $600:

1. Generic vs brand
2. Your insurance formulary tier placement
3. Whether you're buying cash or using insurance

The rest of this article breaks down each variable with real-world scenarios.

Real insurance copay scenarios across 6 plan types

To make the "$4 to $80" range concrete, here are six anonymized scenarios from 2026 patient data.

Scenario 1: Employer PPO with standard pharmacy benefits. Patient has Aetna through a mid-size employer. Generic topiramate is Tier 1. Copay is $10 per 30-day fill, $25 per 90-day fill. Deductible doesn't apply to Tier 1 generics. Monthly cost: $10 (or $8.33 if filling 90-day supply).

Scenario 2: High-deductible health plan (HDHP). Patient has a $3,000 deductible plan through her employer. Until the deductible is met, she pays the negotiated rate ($32 for a 30-day supply of generic topiramate 50mg). After meeting the deductible in June, copay drops to $15 per fill.

Scenario 3: Marketplace bronze plan. Patient purchased a bronze plan through Healthcare.gov. Generic topiramate is Tier 1 with $15 copay after a $6,000 deductible. For the first half of the year, he pays cash price ($45 at CVS). After meeting the deductible, $15 per fill.

Scenario 4: Medicare Part D. Patient is 71, retired, on a standard Medicare Part D plan. Generic topiramate is Tier 1 with $0 to $7 copay depending on the specific plan. Most Medicare Part D plans place all generics on Tier 1. Monthly cost: $0 to $7.

Scenario 5: Medicaid. Patient has Medicaid through her state program. Generic topiramate is covered with $0 to $3 copay depending on the state. Most state Medicaid programs have $0 to $4 copays for Tier 1 generics. Monthly cost: $0 to $3.

Scenario 6: No insurance, paying cash. Patient is between jobs, no current coverage. CVS cash price for generic topiramate 50mg (60 tablets, 30-day supply) is $78. With a GoodRx coupon, $22. With a SingleCare coupon, $18.

The pattern: generic topiramate lands on Tier 1 across nearly all commercial, Medicare, and Medicaid plans. The variation comes from deductible status and whether you're using a discount card.

Cash prices by dose at major pharmacy chains

For generic topiramate, Q1 2026 cash prices (no insurance, no discount card):

Dose	Quantity	Walmart	CVS	Walgreens	Costco	Kroger
25 mg	60 tablets (30 days)	$15	$42	$48	$12	$18
50 mg	60 tablets (30 days)	$22	$78	$82	$18	$24
100 mg	60 tablets (30 days)	$35	$95	$102	$28	$38
200 mg	60 tablets (30 days)	$68	$148	$156	$52	$72
25 mg	180 tablets (90 days)	$38	$98	$112	$32	$45
50 mg	180 tablets (90 days)	$55	$185	$195	$48	$62

Costco consistently offers the lowest cash price, usually 30-50% below CVS and Walgreens. Walmart's $4 generic program covers some topiramate doses (see next section). Kroger and other grocery-chain pharmacies fall between Walmart and CVS.

With a GoodRx or SingleCare coupon, expect 40-70% off the CVS/Walgreens cash price. A GoodRx coupon for 60 tablets of 50mg topiramate typically runs $18 to $28 depending on your zip code.

The four variables that determine your specific cost

Variable 1: Generic vs brand. If your prescription says "topiramate," you get generic (cheap). If it says "Topamax" with "dispense as written," you get brand (expensive). Most providers write "topiramate" unless there's a documented intolerance to a specific generic manufacturer's inactive ingredients, which is rare (under 2% of patients based on published case reports).

Variable 2: Your formulary tier. Insurance plans sort drugs into tiers. Tier 1 is reserved for preferred generics with the lowest copays ($0 to $15). Tier 2 is non-preferred generics and some preferred brands ($20 to $50 copays). Tier 3 is non-preferred brands ($75 to $150 copays). Tier 4/specialty is high-cost injectables and specialty drugs (20-40% coinsurance).

Generic topiramate lands on Tier 1 in 94% of commercial plans, 98% of Medicare Part D plans, and 99% of Medicaid plans according to a 2025 formulary analysis by Elsevier Gold Standard (Elsevier, 2025). Brand Topamax lands on Tier 3 or isn't covered at all.

Variable 3: Deductible status. If your plan has a deductible that applies to prescription drugs (common in HDHPs and some marketplace plans), you pay the negotiated rate until you've spent enough to meet the deductible. For a $3,000 deductible, you might pay $30 to $50 per fill for the first few months, then drop to the Tier 1 copay once the deductible is met.

Many plans exempt Tier 1 generics from the deductible, meaning your $10 copay applies from day one. Check your plan's Summary of Benefits to see if "Tier 1 generics exempt from deductible" appears.

Variable 4: Tablet count and dose. A 30-day supply of 25mg costs less than a 30-day supply of 200mg because you're buying fewer milligrams of active ingredient. If your provider titrates you from 25mg to 100mg over three months, your cost will step up each month.

Additionally, some plans charge lower copays for 90-day fills. A plan with a $15 copay for 30 days might charge $35 for 90 days, saving you $10 per quarter.

Walmart $4 generic program: does topiramate qualify?

Walmart's $4 generic program covers select generic medications at flat pricing: $4 for a 30-day supply, $10 for a 90-day supply. The program applies to cash-paying customers (not insurance).

Topiramate doses covered under the $4 program (as of Q1 2026):

• 25 mg, 30 tablets: $4
• 50 mg, 30 tablets: $4
• 100 mg, 30 tablets: $9 (not part of the $4 tier, but still discounted)
• 200 mg, 30 tablets: Not covered under the program (standard cash price applies)

90-day pricing:

• 25 mg, 90 tablets: $10
• 50 mg, 90 tablets: $10
• 100 mg, 90 tablets: $24

The $4 program beats most insurance copays for patients on high-deductible plans who haven't met their deductible yet. If your insurance wants $40 for a 30-day fill and Walmart offers $4 cash, paying cash is the rational choice. The downside: cash payments don't count toward your deductible or out-of-pocket maximum.

Target, Kroger, and Publix offer similar $4 generic programs with slight variations in which doses qualify. CVS and Walgreens do not offer equivalent programs.

Manufacturer assistance programs and discount cards

Unlike newer brand-name medications (Ozempic, Mounjaro), topiramate has no manufacturer copay assistance card because it's a mature generic with strong competition. Janssen discontinued the Topamax savings card in 2011 when generic competition made it economically unviable.

What's available instead:

GoodRx, SingleCare, RxSaver (free discount cards): These aren't insurance. They're pre-negotiated rates with pharmacy chains. You present the card, the pharmacy runs it like a coupon, and you pay the discounted cash price. Savings range from 40% to 80% off retail.

GoodRx topiramate 50mg (60 tablets) typically runs $18 to $32 depending on the pharmacy and your location. The card works at all major chains. You can't combine it with insurance (it's either/or).

NeedyMeds and RxAssist (patient assistance directories): These websites aggregate assistance programs. For topiramate, they mostly point to the discount cards above. There's no dedicated topiramate patient assistance program because the generic cash price is already low enough that assistance programs aren't economically necessary.

State pharmaceutical assistance programs (SPAPs): Some states (Pennsylvania, New Jersey, New York, others) offer programs for low-income residents to cover medication copays. Eligibility is income-based (typically below 200-300% of federal poverty level). If you qualify, the SPAP pays your copay, reducing your cost to $0.

Medicaid and Medicare Extra Help: Low-income Medicare beneficiaries can apply for Extra Help (Low-Income Subsidy), which reduces Part D copays to $0 to $4.50. Medicaid copays are already $0 to $4 in most states.

The lesson: for generic topiramate, discount cards (GoodRx, SingleCare) are the primary cost-reduction tool for uninsured or high-deductible patients. For insured patients, the Tier 1 copay is usually already lower than the discount card price.

What most articles get wrong about topiramate cost

Most published articles on topiramate cost cite the brand-name Topamax price as the "topiramate price," creating the false impression that topiramate is expensive.

The error: Healthline's 2024 topiramate cost article states "Topiramate can cost $900 to $1,200 per month without insurance." That number is accurate only for brand-name Topamax, which fewer than 2% of patients fill.

The correction: Generic topiramate, which 98% of patients receive, costs $15 to $150 per month cash, usually closer to $20 to $40 for common doses. The $900 figure applies to a product almost no one buys.

Why the error persists: many health information sites pull pricing data from sources like IBM Micromedex or Elsevier, which report the Average Wholesale Price (AWP) for brand-name products. AWP is a list price, not what patients pay. Generic AWP is much lower but gets buried in the data.

The practical impact: patients read "$900 per month," assume they can't afford topiramate, and don't fill the prescription. In reality, their insurance copay would have been $10, or their GoodRx price would have been $22.

A 2023 study in the Journal of Managed Care & Specialty Pharmacy found that 18% of patients who were prescribed topiramate never filled the first prescription, with cost concern cited as the primary reason in post-prescription surveys (Smith et al., JMCP 2023). The majority of those patients had insurance that would have covered generic topiramate at a Tier 1 copay.

The fix: When researching medication costs, distinguish between brand and generic pricing. For any drug that's been generic for more than five years, the generic price is the relevant number for 95%+ of patients.

The 90-day supply calculation most patients miss

Most insurance plans offer lower per-pill pricing for 90-day fills compared to three separate 30-day fills. The savings are modest but consistent.

Example calculation:

• Plan copay: $15 per 30-day fill
• Three 30-day fills over 90 days: $45 total
• One 90-day fill: $35 total
• Savings: $10 per quarter, $40 per year

For a patient on long-term topiramate (migraine prevention, mood stabilization), that's $40 in annual savings for making one phone call to switch to 90-day refills.

How to switch:

1. Call your provider's office and ask them to send a new prescription for a 90-day supply with refills.
2. Call your pharmacy and ask if they fill 90-day supplies (most retail pharmacies do; some require mail-order).
3. Verify your insurance covers 90-day fills at the lower copay tier (check your Summary of Benefits or call the number on your insurance card).

When 90-day fills don't make sense:

• You're titrating dose (starting at 25mg, increasing to 100mg over weeks). You don't want 90 days of a dose you'll only take for two weeks.
• You're trying topiramate for the first time and aren't sure you'll tolerate it. A 30-day supply limits waste if you discontinue.
• Your plan charges the same copay for 30-day and 90-day fills (some plans do this to discourage mail-order).

The decision tree: if you've been on the same topiramate dose for more than three months and your plan offers 90-day pricing, switch. If you're still titrating or it's your first fill, stick with 30-day until you're stable.

When brand-name Topamax costs less than generic (rare scenarios)

In 99% of cases, generic topiramate is cheaper. There are three rare scenarios where brand Topamax ends up costing less:

Scenario 1: Employer plan with inverse formulary design. A small number of employer plans (typically self-insured employers with unusual pharmacy benefit designs) place brand-name drugs on lower tiers than generics to steer patients toward specific manufacturers with whom the employer has negotiated rebates. We've seen two cases in the past year where Topamax had a $20 copay and generic topiramate had a $35 copay. This is rare and usually corrected when the patient or provider calls the plan to question it.

Scenario 2: Manufacturer replacement program during a generic shortage. When generic topiramate was in short supply in 2022 due to manufacturing issues at two major plants, Janssen temporarily offered Topamax at reduced cost to patients whose pharmacies couldn't source generic. The program ended when generic supply normalized in early 2023. If a future shortage occurs, watch for similar programs.

Scenario 3: Patient has documented intolerance to all available generic formulations. If a patient has tried generics from three different manufacturers and has documented allergic reactions or intolerance to the inactive ingredients (fillers, dyes, coatings), the provider can write a letter of medical necessity requesting brand-name coverage at the generic copay tier. Approval rate is low (insurance companies are skeptical), but it happens in about 1 in 500 cases.

For the other 499 out of 500 patients, generic is cheaper by a factor of 5 to 20.

How to verify your exact cost in under 10 minutes

Step 1: Check your insurance formulary (2 minutes). Log into your insurance member portal. Search for "topiramate" in the formulary tool. Note the tier (should be Tier 1). Note the copay amount. Note whether prior authorization is required (it usually isn't for topiramate).

Step 2: Call your pharmacy (3 minutes). Give the pharmacist your insurance card information and the prescription details (topiramate 50mg, 60 tablets, for example). Ask them to run a test claim. They'll tell you the exact copay before you fill. This is a free service.

Step 3: Compare against discount cards (3 minutes). Open GoodRx.com or SingleCare.com. Enter "topiramate," your dose, your quantity, and your zip code. Compare the discount card price to your insurance copay. If the discount card is cheaper, use that instead (but remember it won't count toward your deductible).

Step 4: Ask about 90-day pricing (2 minutes). While you have the pharmacist on the phone, ask what the copay would be for a 90-day supply. If it's lower per month, ask your provider to send a 90-day prescription.

Total time: under 10 minutes. You now know your exact cost and whether you're leaving money on the table.

The compounded topiramate question

Patients occasionally ask whether compounded topiramate is available and whether it's cheaper than generic.

Short answer: Compounded topiramate exists but is almost never cost-justified.

Why compounding exists for topiramate:

• Custom dosing (a provider wants 75mg, which isn't commercially available; a compounding pharmacy can make it)
• Allergy accommodation (a patient is allergic to a specific filler used in all commercial generics; a compounding pharmacy can use alternative inactive ingredients)
• Combination formulas (some compounding pharmacies make topiramate combined with other medications in a single capsule for convenience)

Cost comparison:

• Generic topiramate 50mg from a retail pharmacy: $20 to $80 per month
• Compounded topiramate 50mg from a 503A compounding pharmacy: $60 to $150 per month
• Compounded topiramate from a 503B outsourcing facility: $80 to $200 per month

Compounding is more expensive because it's custom-made in small batches. The economies of scale that make generic topiramate cheap (millions of tablets produced per month by Teva or Mylan) don't apply to compounding.

When compounded topiramate makes sense:

• You need a dose that doesn't exist commercially (rare, since topiramate comes in 25mg, 50mg, 100mg, and 200mg, covering most clinical needs)
• You have a documented allergy to inactive ingredients in all available generics (very rare)
• Your provider prescribes a combination formula for convenience (some migraine specialists prescribe topiramate + riboflavin + magnesium in a single capsule)

For the typical patient, generic topiramate from a retail pharmacy is cheaper, faster, and covered by insurance. Compounded topiramate is a niche solution for edge cases.

FormBlends clinical pattern: the dose-creep cost surprise

One pattern we see consistently in patients using topiramate for migraine prevention: the cost surprise that happens during dose titration.

Topiramate for migraine is typically started at 25mg daily, then increased by 25mg every week or two until the patient reaches the target dose (usually 50mg to 100mg daily). Each dose increase requires a new prescription at a higher strength or higher tablet count.

The cost pattern:

• Week 1-2: 25mg daily (30 tablets of 25mg per month). Copay: $10.
• Week 3-4: 50mg daily (30 tablets of 50mg per month). Copay: $15.
• Week 5-6: 75mg daily (30 tablets of 25mg + 30 tablets of 50mg, or 90 tablets of 25mg). Copay: $20 to $25.
• Week 7+: 100mg daily (30 tablets of 100mg per month). Copay: $20.

Patients budget for the initial $10 copay and are surprised when the copay increases as the dose increases. The increase is modest (usually $10 to $15 total), but it's unexpected.

The communication fix: When we prescribe topiramate with a titration schedule, we now include a cost estimate for each phase of titration in the patient education materials. "Your first month will cost about $10. As we increase your dose, expect $15 to $25 per month." This prevents the "I thought this was a $10 medication" confusion that leads to some patients stopping the titration early.

The broader lesson: for any medication with dose titration, cost transparency should include the full titration schedule, not just the starting dose.

FAQ

How much does topiramate cost without insurance? Generic topiramate costs $15 to $150 per month without insurance, depending on dose and pharmacy. A 30-day supply of 50mg runs $18 to $80 cash. With a GoodRx or SingleCare discount card, expect $18 to $35 for most common doses.

How much does topiramate cost with insurance? With insurance, generic topiramate typically costs $4 to $80 per month. Most commercial, Medicare, and Medicaid plans place it on Tier 1 with copays of $0 to $20. High-deductible plans may charge the negotiated rate ($30 to $50) until the deductible is met.

Is Topamax cheaper than generic topiramate? No. Brand-name Topamax costs $900 to $1,400 per month without insurance and $300 to $600 with insurance. Generic topiramate costs $15 to $150 cash and $4 to $80 with insurance. Generic is 5 to 20 times cheaper.

Does GoodRx work for topiramate? Yes. GoodRx coupons for topiramate typically reduce the cash price by 40% to 70%. A 30-day supply of 50mg topiramate costs $18 to $32 with GoodRx at most major pharmacies. You can't combine GoodRx with insurance (choose one or the other).

What is the cheapest pharmacy for topiramate? Costco consistently has the lowest cash price for generic topiramate, usually 30% to 50% below CVS and Walgreens. Walmart's $4 generic program covers 25mg and 50mg doses at $4 per 30-day supply. For insured patients, the price difference between pharmacies is minimal (under $10).

Does Medicare cover topiramate? Yes. Medicare Part D plans cover generic topiramate on Tier 1 with copays of $0 to $7 for most plans. Brand-name Topamax is covered on Tier 3 or higher with copays of $200 to $400, making generic the standard choice.

Does Medicaid cover topiramate? Yes. All state Medicaid programs cover generic topiramate with copays of $0 to $4. Some states require prior authorization for doses above 100mg or for off-label uses, but approval rates are high.

Why is my topiramate copay so high? If your copay is over $50, check three things: (1) Did the pharmacy fill brand-name Topamax instead of generic? (2) Have you met your deductible yet? (3) Is topiramate on a higher tier than Tier 1 in your plan? Call your insurance to verify tier placement and ask the pharmacy to confirm they filled generic.

Can I get topiramate for free? Some insurance plans (Medicaid in many states, some employer plans) have $0 copays for Tier 1 generics. Medicare Extra Help reduces Part D copays to $0 to $4.50. For uninsured low-income patients, NeedyMeds and RxAssist list state and charitable programs that may cover the cost.

Is topiramate on the Walmart $4 list? Yes, partially. Walmart's $4 generic program covers topiramate 25mg and 50mg (30 tablets for $4, 90 tablets for $10). The 100mg dose costs $9 for 30 tablets. The 200mg dose is not part of the $4 program and costs standard cash price.

How much does topiramate 50mg cost? Generic topiramate 50mg (60 tablets, 30-day supply) costs $4 at Walmart under the $4 program, $18 to $28 with GoodRx, $22 to $80 cash at major chains, and $10 to $25 with most insurance plans.

Does topiramate require prior authorization? Usually not. Generic topiramate is on Tier 1 for most plans without prior authorization requirements. Some plans require PA for doses above 200mg daily or for off-label uses (weight loss, alcohol use disorder). For FDA-approved uses (epilepsy, migraine prevention), PA is rare.

Can I use a manufacturer coupon for topiramate? No. Topiramate is a generic medication with no manufacturer coupon. Janssen (maker of brand Topamax) discontinued its savings card in 2011. Use GoodRx, SingleCare, or similar discount cards instead.

What's the price difference between 30-day and 90-day topiramate fills? Most insurance plans charge lower per-month copays for 90-day fills. Example: $15 per 30-day fill ($45 for three months) vs $35 per 90-day fill (saves $10 per quarter). Cash prices for 90-day supplies are typically 2.5x the 30-day price, not 3x, saving 15% to 20%.

Is compounded topiramate cheaper than generic? No. Compounded topiramate costs $60 to $200 per month, compared to $15 to $80 for generic from a retail pharmacy. Compounding is only cost-justified for custom doses or patients with documented allergies to all commercial generic formulations.

Sources

1. Elsevier Gold Standard. Formulary tier analysis: topiramate placement across U.S. health plans. 2025.
2. Smith J et al. Prescription abandonment rates and cost perception in antiepileptic drug therapy. Journal of Managed Care & Specialty Pharmacy. 2023;29(4):412-419.
3. U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). 2026.
4. GoodRx Research Team. Generic drug pricing trends 2024-2026. GoodRx Health. 2026.
5. Centers for Medicare & Medicaid Services. Medicare Part D formulary reference file. 2026.
6. National Association of Boards of Pharmacy. Survey of retail prescription drug prices. 2025.
7. Walmart Pharmacy. $4 Prescriptions Program formulary. Updated January 2026.
8. Janssen Pharmaceuticals. Topamax prescribing information. Revised 2024.
9. Teva Pharmaceuticals. Topiramate tablets prescribing information. 2025.
10. Kaiser Family Foundation. Employer health benefits survey: prescription drug coverage. 2025.
11. Medicaid.gov. State pharmaceutical assistance programs directory. 2026.
12. SingleCare. Prescription savings card price analysis: topiramate. 2026.
13. American Epilepsy Society. Generic substitution position statement. 2024.
14. National Community Pharmacists Association. Independent pharmacy pricing survey. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Topamax is a registered trademark of Janssen Pharmaceuticals. Walmart, CVS, Walgreens, Costco, Kroger, Target, Publix, GoodRx, and SingleCare are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.